Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

ADAPALENE AND BENZOYL PEROXIDE

ADAPALENE; BENZOYL PEROXIDE

Standard Dose
0.3%;2.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ADAPALENE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 214553 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ADAPALENE; BENZOYL PEROXIDE Form and strength GEL;TOPICAL - 0.3%;2.5% Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2022-06-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADAPALENE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 214553 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADAPALENE; BENZOYL PEROXIDE Form and strength GEL;TOPICAL - 0.3%;2.5% Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2022-06-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.